Dr. Kelvin Lee being filmed by a NOVA crew in a laboratory at Roswell Park

Reminder: Tune in April 1 as “NOVA” Features Roswell Park’s Role with Cuban Lung Cancer Vaccine

Pictured: Kelvin Lee, MD, being filmed by a "NOVA" crew in a laboratory at Roswell Park

Roswell Park hits the spotlight tonight, Wednesday, April 1, in an episode of the science documentary series “NOVA.” Tune in to your local PBS station for “Cuba’s Cancer Hope,” a look at how Cuba came to develop several important medical therapies, including CIMAvax-EGF® and other promising cancer vaccines.

Kelvin Lee, MD, Senior Vice President for Basic Science and Chair of Immunology at Roswell Park, says the potential to treat — or maybe even prevent — many types of cancer with Cuban-developed therapies is “enormous.”

Part of the episode will focus on Roswell Park’s historic partnership with Cuba’s Centro de Immunología Molecular (CIM), developer of CIMAvax-EGF. Roswell Park is the only center in the country offering this groundbreaking treatment, which is currently available through a clinical trial for eligible patients with non-small cell lung cancer or squamous cell head and neck cancer.

In addition to Dr. Lee, several Roswell Park experts were interviewed for the segment, including Candace Johnson, PhD, President and CEO; Kunle Odunsi, MD, PhD, Deputy Director, Executive Director of Roswell Park’s Center for Immunotherapy and Chair of the Department of Gynecologic Oncology; Grace Dy, MD, Chief of Thoracic Oncology; and Mary Reid, PhD, MSPH, Director of Cancer Screening and Survivorship.

In Western New York, “Cuba’s Cancer Hope” airs at 9 p.m. on WNED-TV.